Description

Bifendate (CAS: 73536-69-3) is a synthetic biphenyl derivative with the molecular formula C₂₀H₁₈O₁₀. This high-purity compound is widely utilized in pharmaceutical research, particularly in hepatoprotective studies, due to its ability to modulate liver enzyme activity and mitigate oxidative stress. Bifendate exhibits excellent stability under standard laboratory conditions and is supplied as a fine white to off-white crystalline powder with ≥98% purity (HPLC). It is soluble in organic solvents such as DMSO and ethanol but has limited solubility in aqueous solutions. Each batch undergoes rigorous QC testing, including NMR, HPLC, and MS analysis, ensuring consistency for research applications. Suitable for in vitro and in vivo studies, this product is packaged under inert gas to prevent degradation.

Properties

• CAS Number: 73536-69-3
• Complexity: 587
• IUPAC Name: methyl 7-methoxy-4-(7-methoxy-5-methoxycarbonyl-1,3-benzodioxol-4-yl)-1,3-benzodioxole-5-carboxylate
• InChI: InChI=1S/C20H18O10/c1-23-11-5-9(19(21)25-3)13(17-15(11)27-7-29-17)14-10(20(22)26-4)6-12(24-2)16-18(14)30-8-28-16/h5-6H,7-8H2,1-4H3
• InChI Key: JMZOMFYRADAWOG-UHFFFAOYSA-N
• Exact Mass: 418.08999677
• Molecular Formula: C20H18O10
• Molecular Weight: 418.3
• SMILES: COC1=C2C(=C(C(=C1)C(=O)OC)C3=C4C(=C(C=C3C(=O)OC)OC)OCO4)OCO2
• Topological: 108
• Monoisotopic Mass: 418.08999677
• Synonyms: Bifendate, .alpha.-ddb, CCRIS 7767, methyl 7-methoxy-4-(7-methoxy-5-methoxycarbonyl-1,3-benzodioxol-4-yl)-1,3-benzodioxole-5-carboxylate, Dimethyl dicarboxylate biphenyl, Diphenyl dimethyl bicarboxylate, 7,7′-Dimethoxy-(4,4′-bi-1,3-benzodioxole)-5,5′-dicarboxylic acid dimethyl ester, BRN 5461320, UNII-0G32E321W1, 0G32E321W1, BIFENDATE [WHO-DD], DTXSID40223736, Dimethyl 7,7′-dimethoxy-(4,4′-Bi-1,3-benzodioxole)-5,5′-dicarboxylate, Dimethyl-4,4′-dimethoxyl-5,6,5′,6′-dimethylenedioxybiphenyl-2,2′-dicarboxylate, Dimethyl 4,4′-dimethoxy-5,6,5′,6′-bis(methylenedioxy)biphenyl-2,2′-dicarboxylate, (4,4′-Bi-1,3-benzodioxole)-5,5′-dicarboxylic acid, 7,7′-dimethoxy-, dimethyl ester, DIMETHYL-4,4′-DIMETHOXY-5,6,5′,6′-DIMETHYLENEDIOXYBIPHENYL-2,2′-DICARBOXYLATE, (4,4′-BI-1,3-BENZODIOXOLE)-5,5′-DICARBOXYLIC ACID, 7,7′-DIMETHOXY-, 5,5′-DIMETHYL ESTER, ALPHA-DDB, dimethyl 4,4′-dimethoxy-5,6,5′,6′-dimethylenedioxybiphenyl-2,2′-dicarboxylate, DTXCID70146227, 73536-69-3, Bifendatatum, Dimethyl 7,7′-dimethoxy-[4,4′-bibenzo[d][1,3]dioxole]-5,5′-dicarboxylate, MFCD01751431, [4,4′-Bi-1,3-benzodioxole]-5,5′-dicarboxylic acid, 7,7′-dimethoxy-,dimethyl ester, alpha-diphenyldicarboxylate, biphenyl dimethyl-dicarboxylate, diphenyl dimethyl dicarboxylate, dimethyl diphenyl bicarboxylate, Bifendate, (R)-, Bifendate, (S)-, CE2LBA6CBR, PP685NHP9Z, SCHEMBL896166, CHEMBL105184, HMS5083B22, BCP12613, BDBM50289527, MSK164571, s4890, AKOS015895317, CCG-268865, CS-W019577, HY-W018791, SB67338, AS-13115, FD139796, SY021274, B6112, NS00116009, AN-786/13677002, BRD-K26581543-001-01-6, Q27236735, 2,2′-Dimethoxycarbonyl-4,4′-dimethoxy-5,6,5′,6′-bismethylenedioxybiphenyl, 7,7′-dimethoxy-5,5′-bis(methoxycarbonyl)-4,4′-bis(1,3-benzodioxole), Dimethyl7,7′-dimethoxy-[4,4′-bibenzo[d][1,3]dioxole]-5,5′-dicarboxylate, [4,4′-Bi-1,3-benzodioxole]-5,5′-dicarboxylic acid, 7,7′-dimethoxy-, dimethyl ester, (4R)-, [4,4′-Bi-1,3-benzodioxole]-5,5′-dicarboxylic acid, 7,7′-dimethoxy-, dimethyl ester, (4S)-, [4,4′-Bi-1,3-benzodioxole]-5,5′-dicarboxylic acid, 7,7′-dimethoxy-, dimethyl ester, (R)-, [4,4′-Bi-1,3-benzodioxole]-5,5′-dicarboxylic acid, 7,7′-dimethoxy-, dimethyl ester, (S)-, 111897-25-7, 111897-26-8, Dimethyl 7 pound not7′-dimethoxy-[4 pound not4′-bibenzo[d][1 pound not3]dioxole]-5 pound not5′-dicarboxylate, Dimethyl 7,7 inverted exclamation mark -Dimethoxy-[4,4 inverted exclamation mark -bi-1,3-benzodioxole]-5,5 inverted exclamation mark -dicarboxylate

Bifendate is primarily used in hepatology research as a reference standard for studying liver protection mechanisms. It demonstrates significant anti-fibrotic effects in models of hepatic injury by downregulating TGF-β1 signaling pathways. Researchers employ this compound to investigate its antioxidative properties against CCl₄-induced liver damage. In pharmacokinetic studies, it serves as a marker for biphenyl metabolism. Current clinical research explores its potential as an adjuvant therapy for chronic hepatitis B.

If you are interested or have any questions, please contact us at support@atomfair.com

Disclaimer: Sold exclusively for laboratory research. Prohibited for commercial use, diagnostics, or human/animal applications. Buyers assume all compliance liability.